» Articles » PMID: 28138128

Understanding and Preventing Contrast-induced Acute Kidney Injury

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2017 Feb 1
PMID 28138128
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

Contrast-induced acute kidney injury (CIAKI) occurs in up to 30% of patients who receive iodinated contrast media and is generally considered to be the third most common cause of hospital-acquired AKI. Accurate assessment of the incidence of CIAKI is obscured, however, by the use of various definitions for diagnosis, the different populations studied and the prophylactic measures put in place. A deeper understanding of the mechanisms that underlie CIAKI is required to enable reliable risk assessment for individual patients, as their medical histories will determine the specific pathways by which contrast media administration might lead to kidney damage. Here, we highlight common triggers that prompt the development of CIAKI and the subsequent mechanisms that ultimately cause kidney damage. We also discuss effective protective measures, such as rapidly acting oral hydration schemes and loop diuretics, in the context of CIAKI pathophysiology. Understanding of how CIAKI arises in different patient groups could enable a marked reduction in incidence and improved outcomes. The ultimate goal is to shape CIAKI prevention strategies for individual patients.

Citing Articles

Lymphocyte to c-reactive protein ratio predicts the risk of contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention.

Xiang L, Qiu B, Chen L, Wang C, Zhang W, Liu L BMC Cardiovasc Disord. 2025; 25(1):140.

PMID: 40021983 PMC: 11869660. DOI: 10.1186/s12872-025-04522-0.


Chronic Kidney Disease Following Cardiac Arrest Manifesting as Dyspnoea and Peripheral Oedema in Cardiovascular Multimorbidity: Case Analysis and Brief Literature Review.

Harding K, Emblin K, Ichim A, Adlington D, Daniels R, Mokbel K In Vivo. 2025; 39(2):1182-1189.

PMID: 40010965 PMC: 11884450. DOI: 10.21873/invivo.13922.


Clinical outcomes of intravenous urography-assisted shockwave lithotripsy for radiolucent ureteral stones.

Somiya S, Koterazawa S, Ito K, Haitani T, Makino Y, Arakaki R Asian J Urol. 2025; 12(1):66-71.

PMID: 39990064 PMC: 11840302. DOI: 10.1016/j.ajur.2024.03.002.


Impact of on coronary computed tomography angiography image quality and renal function in a beagle model of renal impairment.

Song P, Li K, Xu X, Zhang G, Wang Z, Sun L Front Pharmacol. 2025; 16:1538916.

PMID: 39944630 PMC: 11813939. DOI: 10.3389/fphar.2025.1538916.


Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases.

Dugbartey G, Alornyo K, Dapaa-Addo C, Botchway E, Kwashie E, Harley Y Curr Res Pharmacol Drug Discov. 2024; 7:100206.

PMID: 39524210 PMC: 11550178. DOI: 10.1016/j.crphar.2024.100206.


References
1.
Liss P, Persson P, Hansell P, Lagerqvist B . Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int. 2006; 70(10):1811-7. DOI: 10.1038/sj.ki.5001887. View

2.
Damkjaer M, Isaksson G, Stubbe J, Jensen B, Assersen K, Bie P . Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch. 2012; 465(1):153-65. DOI: 10.1007/s00424-012-1171-2. View

3.
Ueda J, Nygren A, Hansell P, ULFENDAHL H . Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol. 1993; 34(1):83-7. View

4.
Solomon R, Segal A . Defining acute kidney injury: what is the most appropriate metric?. Nat Clin Pract Nephrol. 2008; 4(4):208-15. DOI: 10.1038/ncpneph0746. View

5.
Davenport M, Khalatbari S, Cohan R, Dillman J, Myles J, Ellis J . Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology. 2013; 268(3):719-28. DOI: 10.1148/radiol.13122276. View